Patrys Limited (PAB.AX) Release: PAT-SM6 Kills Human Multiple Myeloma Cells
5/8/2013 9:33:59 AM
More...
|
Patrys Limited (PAB.AX) Progresses Multiple Myeloma Clinical Trial to Third Patient Group
4/24/2013 9:31:54 AM
More...
|
Patrys Limited (PAB.AX) Release: New Data Strengthens PAT-SM6 Profile as an Anti-Cancer Treatment
4/22/2013 9:26:05 AM
More...
|
Patrys Limited (PAB.AX) Completes Treatment of Second Patient Group in Multiple Myeloma Trial
4/10/2013 9:45:05 AM
More...
|
Patrys Limited (PAB.AX) Release: Data From 1st Cohort of Patients in Multiple Myeloma Clinical Trial
3/7/2013 10:43:08 AM
More...
|
Patrys Limited (PAB.AX) Progresses Multiple Myeloma Clinical Trial to Second Patient Group
1/14/2013 10:23:27 AM
More...
|
Patrys Limited (PATZF.PK) Completes Treatment of First Patient Group in Multiple Myeloma Trial
12/10/2012 11:33:17 AM
More...
|
Patrys Limited (PATZF.PK) Enrolls First Patient in Multiple Myeloma Trial
11/7/2012 9:57:44 AM
More...
|
Patrys Limited (PATZF.PK) Receives Australian Ethics Approval for Multiple Myeloma Trial
11/2/2012 3:07:47 PM
More...
|
Patrys Limited (PATZF.PK) Receives Regulatory Approval for Multiple Myeloma Trial
9/20/2012 10:08:11 AM
More...
|
|